Anti-C19orf35 antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | C19orf35 |
| Immunogen: | Recombinant protein |
| Species immunized: | Mouse |
| Isotype: | IgG1 |
| Applications: | Western Blot (1:400-1:1000); Immunohistochemistry (1:100-1:200); Immunocytochemistry (1:100-1:200) |
| Reactivity: | Human |
| Clonality (clone number): | Monoclonal, 3-B7-G3 |
| Form: | Liquid |
| Buffer: | 1*TBS (pH7.4), 1%BSA, 0.05% NaN3 and 40% Glycerol. |
| Concentration: | 2mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | C19orf35 antibody |
| Chromosome 19 open reading frame 35 antibody | |
| CS035_HUMAN antibody | |
| FLJ45778 antibody | |
| Putative uncharacterized protein C19orf35 antibody |
Target information
C19orf35 and CNRIP1 were specific to diffuse-type compared to the intestinal-type subgroups. Both revealed a similar level of methylation in CNM regardless of the histologic subtype of tumor while the methylation of the tumor tissue varied with the histologic type. C19orf35 was hypermethylated but CNRIP1 was hypomethylated in diffuse-type tumors compared to the CNM while it had an opposite trend in the tumors of the intestinal-type and mixed-type subgroups. Importantly, research suggest the possibility of utilizing these genes as specific markers for diffuse-type GCs. On the other hand, the function of C19orf35 is still unknown while frequent methylation of CNRIP1 has recently been reported in colorectal cancers and adenoma.
Provider
Erpantech Laboratory
